2‐Methoxyestradiol, a Promising Anticancer Agent
Nehal J. Lakhani(South Texas Accelerated Research Therapeutics), William D. Figg(National Cancer Institute), Jürgen Venitz(National Cancer Institute), Mohamadi Sarkar(National Cancer Institute)
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
February 1, 2003
Cited by 276
Related Papers
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
|Journal of Clinical Oncology|2019|590